Oklo Inc.

(New York Stock Exchange)
Back to all articles
Slightly Bearish -20

Oklo (NYSE:OKLO) General Counsel Sells $12,627.16 in Stock

Insider transaction AI-generated analysis

πŸ“‰ Oklo General Counsel Vivek Narayanadas sold 364 shares for $12,627.16 to cover tax withholding obligations under a pre-arranged Rule 10b5-1 trading plan.

πŸ“ˆ Oklo reported quarterly revenue of $1.21 million, which was 11,900% higher than the previous year and significantly beat analyst estimates of $0.09 million.

πŸ’° The company posted a loss of $0.28 per share for the quarter, missing consensus estimates of a smaller loss of $0.16 per share.

🏦 Institutional investors and hedge funds own 85.03% of Oklo's stock, with several firms like Accel Wealth Management and Thor Investment Management adding new positions in Q3.

πŸ“‰ UBS Group reduced its price target on Oklo from $55.00 to $41.00 and assigned a neutral rating in a recent research note.

πŸ“‰ Citigroup decreased its price target on Oklo from $76.00 to $57.50 while maintaining a neutral rating on the stock.

πŸ“ˆ Truist Financial set a price objective of $51.00 for Oklo shares in a research report dated September 28th.

🏭 Oklo is developing compact nuclear power plants, including its flagship Aurora system, designed to provide carbon-free electricity to industrial and commercial users.

πŸ”¬ The company is actively pursuing partnerships and regulatory work in the United States, with initial focus on serving the U.S. market and activities at Idaho National Laboratory.

πŸ“Š Oklo has a market capitalization of $5.92 billion and a beta of 1.20, indicating higher volatility relative to the broader market.

Bullish Signals
  • Oklo reported quarterly revenue of $1.21 million, which was 11,900% higher than the previous year and significantly beat analyst estimates of $0.09 million.
  • Institutional investors and hedge funds own 85.03% of the company's stock, indicating strong confidence from major market participants.
  • Truist Financial set a price objective of $51.00 for Oklo shares in a research report dated September 28th.
Risk Factors
  • Oklo posted a loss of $0.28 per share for the quarter, missing consensus estimates of a smaller loss of $0.16 per share.
  • UBS Group reduced its price target on Oklo from $55.00 to $41.00 and assigned a neutral rating in a recent research note.
  • Citigroup decreased its price target on Oklo from $76.00 to $57.50 while maintaining a neutral rating on the stock.
Full Analysis
Oklo Inc. (NYSE:OKLO) General Counsel Vivek Narayanadas sold 364 shares of the company's stock on Friday, October 9th, for a total value of $12,627.16 at an average price of $34.69 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan specifically to cover tax withholding obligations related to the vesting of equity awards. Following this sale, Narayanadas retains direct ownership of 8,769 shares, valued at approximately $304,196.61, representing a 3.99% decrease in his total holdings. Oklo reported its quarterly earnings results on Friday, August 7th, delivering revenue of $1.21 million which significantly beat analyst estimates of $0.09 million, marking an 11,900% year-over-year increase. Despite the strong top-line growth, the company posted a loss of $0.28 per share, missing consensus estimates of a smaller loss of $0.16. The stock currently trades with a market capitalization of $5.92 billion and has seen significant institutional interest, with hedge funds and institutional investors owning 85.03% of the company's outstanding shares. Analyst sentiment regarding Oklo remains mixed as major financial institutions have recently adjusted their price targets downward. UBS Group reduced its target price from $55.00 to $41.00 with a neutral rating, while Citigroup lowered its target from $76.00 to $57.50, also maintaining a neutral stance. Conversely, Truist Financial set a higher price objective of $51.00 in late September, and Barclays maintains an overweight rating with a target of $76.00. The consensus rating among sell-side analysts is currently 'Moderate Buy' with an average price target of $82.44.